Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infections in multiple myeloma.

F Paradisi1, G Corti, R Cinelli

  • 1Clinic of Infectious Diseases, University of Florence School of Medicine, Florence, Italy.

Infectious Disease Clinics of North America
|July 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026
Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026
Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026
Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026
Same author

AFM Force Volume for Extracellular Vesicle Detection and Membrane Blebbing Analysis Through Mechanical Signature Mapping.

Journal of molecular recognition : JMR·2026
Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026

Multiple myeloma patients experience severe immune suppression, increasing risks of serious infections. Early diagnosis and prompt anti-infective treatment are crucial to reduce mortality in these hematologic malignancy cases.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Background:

  • Multiple myeloma is a severe hematologic malignancy.
  • Patients often exhibit immune suppression due to the disease and treatments like chemotherapy or stem cell transplantation.
  • This immune deficiency leads to high rates of serious infections.

Purpose of the Study:

  • To highlight the significant risk of infections in multiple myeloma patients.
  • To emphasize the critical role of immune system suppression in disease morbidity and mortality.
  • To underscore the necessity of prompt diagnosis and effective anti-infective strategies.

Main Methods:

  • Review of clinical data and literature concerning multiple myeloma.
  • Analysis of factors contributing to immune suppression (e.g., immunoglobulin deficiency, neutropenia, therapies).

Related Experiment Videos

  • Examination of infection patterns and outcomes in affected patients.

    • Main Results:

    • Multiple myeloma and its treatments (alkylant/steroid therapy, BMT/SCT) markedly suppress immune function.
    • Patients are highly susceptible to recurrent bacterial, fungal, and viral infections.
    • Infections are a primary cause of morbidity and the leading cause of death.

    Conclusions:

    • Prompt diagnosis of infections is essential for multiple myeloma patients.
    • Appropriate anti-infective chemotherapy is critical for reducing mortality.
    • Managing immune suppression is key to improving patient outcomes in multiple myeloma.